Anika Therapeutics Inc banner

Intrinsic Value

The intrinsic value of Anika Therapeutics Inc (AKP) under the Base Case is 19.39 EUR per share. Compared with the current market price of 11.8 EUR, the stock appears Undervalued by 39% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

AKP Intrinsic Value
€19.39
Undervaluation 39%
Intrinsic Value
Price €11.8
Alert me when AKP is below its intrinsic value
Today €11.64 · 1.4% below the current price

AKP is cheaper than usual. It was this cheap or cheaper on just 15% of days in the past 5 years.

Alternatives to AKP

Fundamental Analysis

What Anika Therapeutics Does

Biotechnology Health Care

Anika Therapeutics makes medical products that help doctors treat joint pain and support healing in bones and soft tissue. Its best-known products are based on hyaluronic acid, a substance used in joint injections and surgical care, and it also sells orthopedic and tissue-healing products used in procedures such as knee, hip, and sports-medicine treatment.

Headquarters
United States of America US
Employees
235
IPO date
May 16, 1985
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

Anika Therapeutics insiders are buying within their usual range

Insider trading · Last trade on Aug 4, 2026

Sold $0 Nobody sold
Bought $264.3k 3 insiders
Trades by date
Open insider trading

Continue AKP Research

Decided on Anika Therapeutics? Get an email when AKP reaches the price you’d buy at. Free with an account.

Other Anika Therapeutics listings

What is the Intrinsic Value of one AKP stock?

The intrinsic value for Anika Therapeutics Inc (AKP) under the Base Case is 19.39 EUR.

Is AKP stock undervalued or overvalued?

Compared with the current market price of 11.8 EUR, the stock appears Undervalued by 39% .

How reliable are our estimates? See how past valuations played out
Back to Top